By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced the close of its Series E round of financing, which raised $100 million and brings the total capital raised by the company in its history to more than $259 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.